![]() |
ACS News Center | |||||
|
|
||||||
|
||||||
| Therapy May Provide Hope For Pancreatic Cancer Patients | |
| Alternative Therapy for Pancreatic Cancer Moves to Clinical Trials | |
| Article date: 2000/01/12 |
A pilot study of an alternative treatment for pancreatic cancer has led
to a clinical trial funded by the National Cancer Institute (NCI). The
therapy, promoted by New York immunologist Nicholas Gonzales, MD, consists
of a specialized diet, high doses of vitamins and enzymes, and detoxification
procedures to rid the body of "tumor debris."
Dr. Gonzales said the pilot study and resulting clinical trial offers some hope for patients with pancreatic cancer, which has a one-year relative survival rate of only 19 percent and a five-year rate of only 4 percent. "We desperately need better treatment for pancreatic cancer, of which the majority of patients die and die quickly because we do not have any good therapy for it," said Barrie Cassileth, PhD, chief of integrative medicine, Memorial Sloan-Kettering Cancer Center. "It would be very exciting if this approach turns out to be beneficial, though many oncologists are skeptical and believe that even though the case results look promising, the end result will not support the validity of the trials. That’s exactly why trials are necessary." The purpose of pilot studies, which involve a very small number of patients, is to find out if a treatment has any significant effect on the cancer. If some evidence is seen, the treatment moves into the next phase of testing. Pilot studies do not provide definitive proof of effectiveness. As of January 12, 1999, nine of 11 patients in the pilot study had survived one year; five had survived two years; and four had survived four years. One of Dr. Gonzales’ patients, who has been following the regimen (which includes 150 supplements per day) since 1991, is 75 years old and in excellent health, showing no evidence of disease. Changes in Diet The supplements include vitamins, minerals, and trace elements as a
supportive, not an anticancer, regimen. Dr. Gonzales also prescribes certain
freeze-dried organ concentrates such as thymus and liver. Each patient
takes a capsule of porcine (pig) lyophilized (freeze-dried) pancreas product
daily.
The clinical trial was originally set up as a randomized study, but an initial flood of interested patients revealed they wanted to be in the trial only if they could get the alternative treatment. As a result, NCI changed the trial to a non-randomized study so patients may choose between chemotherapy and the alternative therapy. If the trial is successful, Dr. Gonzales said, it would mean that this regimen could become an accepted therapy like radiation or chemotherapy. "I applaud Dr. Gonzales for his willingness and courage to participate
in this kind of study where he’s willing to turn over [his treatment] for
review to a major comprehensive cancer center and take the results, whatever
they might be," Dr. Cassileth said.
ACS News Center stories are provided as a source of cancer-related news and are not intended to be used as press releases. |